Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 5

Multi-targeted approach in the treatment of thyroid cancer

Authors Scott N Pinchot, Rebecca S Sippel, Herbert Chen

Published Date August 2008 Volume 2008:4(5) Pages 935—947

DOI http://dx.doi.org/10.2147/TCRM.S3062

Published 4 August 2008

Scott N Pinchot, Rebecca S Sippel, Herbert Chen1

1Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin Madison, Wisconsin, USA

Abstract: While accounting for only 1% of solid organ malignancies (9% in women), thyroid carcinoma is the most common malignancy of the endocrine system. Although most patients have a favorable prognosis, over 1,500 people will die from thyroid carcinoma each year. The spectrum of disease types range from papillary thyroid cancer, which is a well-differentiated indolent tumor, to anaplastic carcinoma, a poorly differentiated fulminant cancer. With advances in diagnostic methods, surgical techniques, and clinical care of patients with thyroid carcinoma, the current management of thyroid cancer demands a multidisciplinary approach. The majority of patients with well-differentiated thyroid carcinoma of follicular cell origin are cured with adequate surgical management; however, some thyroid malignancies such as medullary thyroid carcinoma (MTC) or poorly differentiated thyroid carcinomas frequently metastasize, precluding patients from a curative resection. As such, novel palliative and therapeutic strategies are needed for this patient population. Here, we explore the current management of thyroid carcinoma, including surgical management of the primary tumor, lymph node disease, and locoregional recurrence. Likewise, we explore the application of current molecular techniques, reviewing nearly two decades of data that have begun to elucidate critical genetic pathways and therapeutic drug targets which may be important in specific thyroid tumor types.

Keywords: thyroid carcinoma; vascular endothelial growth factor receptor (VEGFR); epidermal growth factor receptor (EGFR); RET tyrosine kinase (RTK); glycogen synthase kinase-3β (GSK-3β)

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Quality of dementia clinical guidelines and relevance to the care of older people with comorbidity: evidence from the literature

Damiani G, Silvestrini G, Trozzi L, Maci D, Iodice L, Ricciardi W

Clinical Interventions in Aging 2014, 9:1399-1407

Published Date: 20 August 2014

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Expression of concern]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:1333-1334

Published Date: 18 July 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Acute bilateral angle closure glaucoma induced by methazolamide

Aref AA, Sayyad FE, Ayres B, Lee RK

Clinical Ophthalmology 2013, 7:279-282

Published Date: 11 February 2013

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease

Mannu P, Rinaldi S, Fontani V, Castagna A

Clinical Interventions in Aging 2011, 6:207-211

Published Date: 26 July 2011

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Paul Shotbolt, Michael Samuel, Chris Fox, Anthony S David

Neuropsychiatric Disease and Treatment 2009, 5:327-332

Published Date: 25 May 2009

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review

Ashish Chandwani, Jonathan Shuter

Therapeutics and Clinical Risk Management 2008, 4:1023-1033

Published Date: 8 September 2008

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Jeffrey R Bishop, Mani N Pavuluri

Neuropsychiatric Disease and Treatment 2008, 4:55-68

Published Date: 4 March 2008

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder

Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, A Carlo Altamura

Neuropsychiatric Disease and Treatment 2006, 2:139-148

Published Date: 18 February 2006

Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration

Irene Hegeman Richard, Samuel Frank, Kori A LaDonna, Hongkun Wang, Michael P McDermott, Roger Kurlan

Neuropsychiatric Disease and Treatment 2005, 1:261-268

Published Date: 18 February 2005